Company: INDP
Filing Date: 2025-02-05
Form Type: S-3
Source: 0001493152-25-005016
Chunk: 2

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-02-05
Form: S-3
Chunk 2
---
. This preliminary prospectus is not an offer to sell these securities and we are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

<div align='center'>SUBJECT TO COMPLETION, DATED FEBRUARY 5, 2025</div>

PROSPECTUS

<div align='center'>4,366,422 Shares of Common Stock</div>

This prospectus relates to the proposed resale or other disposition, by the selling stockholders identified in this prospectus, of an aggregate of up to 4,366,422 shares of common stock, par value $0.01 per share, of Indaptus Therapeutics Inc. consisting of (i) 2,109,383 shares of common stock issued in a private placement in January 2025, or the January 2025 Private Placement, (ii) 2,109,383 shares of common stock issuable upon the exercise of investor warrants in the January 2025 Private Placement, and (iii) 147,656 shares of common stock issuable upon exercise of placement agent warrants issued in connection with the January 2025 Private Placement. We refer to the investor warrants and placement agent warrants collectively as warrants.

We will not receive any proceeds from the sale of the shares of our common stock by the selling stockholders. All net proceeds from the sale of the shares of our common stock covered by this prospectus will go to the selling stockholders. However, we may receive the proceeds from any exercise of warrants if the holders do not exercise the warrants on a cashless basis. See “Use of Proceeds.”

The selling stockholders and any of their pledgees, donees, transferees, assignees or other successors-in-interest may, from time to time, sell, transfer or otherwise dispose of any or all of their shares of common stock or interests in shares of common stock on any stock exchange, market or trading facility on which the shares are traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices. See “Plan of Distribution.”

Our common stock is listed on the Nasdaq Capital Market under the symbol “INDP”. On February 4, 2025, the last reported sale price of our common stock on the Nasdaq Capital Market was $0.917 per share.

Investing in